{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T23:59:42Z","timestamp":1747180782540,"version":"3.40.5"},"reference-count":53,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T00:00:00Z","timestamp":1696636800000},"content-version":"vor","delay-in-days":371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Nutrition"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1093\/jn\/nxac154","type":"journal-article","created":{"date-parts":[[2022,9,10]],"date-time":"2022-09-10T00:26:13Z","timestamp":1662769573000},"page":"2218-2226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Palmitoylethanolamide Reduces Proinflammatory Markers in Unvaccinated Adults Recently Diagnosed with COVID-19: A Randomized Controlled Trial"],"prefix":"10.1016","volume":"152","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5186-4242","authenticated-orcid":false,"given":"Samantha N","family":"Fessler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4002-7497","authenticated-orcid":false,"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yung","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa","family":"Yip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol S","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1093\/jn\/nxac154_bib1","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1039\/C6MB00240D","article-title":"Molecular and genetic inflammation networks in major human diseases","volume":"12","author":"Zhao","year":"2016","journal-title":"Mol Biosyst."},{"key":"10.1093\/jn\/nxac154_bib2","doi-asserted-by":"crossref","first-page":"111143","DOI":"10.1016\/j.biopha.2020.111143","article-title":"Could natural products modulate early inflammatory responses, preventing acute respiratory distress syndrome in COVID-19-confirmed patients?","volume":"134","author":"Amaral-Machado","year":"2021","journal-title":"Biomed Pharmacother."},{"issue":"2","key":"10.1093\/jn\/nxac154_bib3","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jpha.2020.03.001","article-title":"Molecular immune pathogenesis and diagnosis of COVID-19","volume":"10","author":"Li","year":"2020","journal-title":"J Pharm Anal."},{"key":"10.1093\/jn\/nxac154_bib4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cytogfr.2020.05.002","article-title":"COVID-19: pathogenesis, cytokine storm and therapeutic potential of interferons","volume":"54","author":"Nilea","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1","key":"10.1093\/jn\/nxac154_bib5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41392-021-00653-w","article-title":"Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy","volume":"6","author":"Zhang","year":"2021","journal-title":"Signal Transduct Target Ther."},{"issue":"1","key":"10.1093\/jn\/nxac154_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2 entry into cells","volume":"23","author":"Jackson","year":"2022","journal-title":"Nat Rev Mol Cell Biol."},{"issue":"3","key":"10.1093\/jn\/nxac154_bib7","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","article-title":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","volume":"63","author":"Liu","year":"2020","journal-title":"Sci China Life Sci."},{"key":"10.1093\/jn\/nxac154_bib8","doi-asserted-by":"crossref","first-page":"117905","DOI":"10.1016\/j.lfs.2020.117905","article-title":"Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to macrophage activation syndrome: therapeutic implications","volume":"256","author":"Banu","year":"2020","journal-title":"Life Sci."},{"issue":"1","key":"10.1093\/jn\/nxac154_bib9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s12272-020-01301-7","article-title":"Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective","volume":"44","author":"Lee","year":"2021","journal-title":"Arch Pharmacal Res."},{"key":"10.1093\/jn\/nxac154_bib10","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.3389\/fimmu.2020.01229","article-title":"Innate immune signaling and proteolytic pathways in the resolution or exacerbation of SARS-CoV-2 in COVID-19: key therapeutic targets?","volume":"11","author":"Sallenave","year":"2020","journal-title":"Front Immunol."},{"issue":"10223","key":"10.1093\/jn\/nxac154_bib11","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet."},{"issue":"12","key":"10.1093\/jn\/nxac154_bib12","doi-asserted-by":"crossref","first-page":"E468","DOI":"10.1002\/ajh.26372","article-title":"Plasma P-selectin is an early marker of thromboembolism in COVID-19","volume":"96","author":"Fenyves","year":"2021","journal-title":"Am J Hematol."},{"issue":"7","key":"10.1093\/jn\/nxac154_bib13","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41591-020-0968-3","article-title":"Extrapulmonary manifestations of COVID-19","volume":"26","author":"Gupta","year":"2020","journal-title":"Nat Med."},{"issue":"4","key":"10.1093\/jn\/nxac154_bib14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41577-021-00522-1","article-title":"The first 12 months of COVID-19: a timeline of immunological insights","volume":"21","author":"Carvalho","year":"2021","journal-title":"Nat Rev Immunol."},{"issue":"2","key":"10.1093\/jn\/nxac154_bib15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41590-021-01113-x","article-title":"Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection","volume":"23","author":"Phetsouphanh","year":"2022","journal-title":"Nat Immunol."},{"key":"10.1093\/jn\/nxac154_bib16","first-page":"1","article-title":"Palmitoylethanolamide: a natural body-own anti-inflammatory agent, effective and safe against influenza and common cold","volume":"2013","author":"Keppel Hesselink","year":"2013","journal-title":"Int J Inflam."},{"issue":"11","key":"10.1093\/jn\/nxac154_bib17","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/bph.13580","article-title":"The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations","volume":"174","author":"Petrosino","year":"2017","journal-title":"Br J Pharmacol."},{"issue":"1","key":"10.1093\/jn\/nxac154_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1124\/mol.104.006353","article-title":"The nuclear receptor peroxisome proliferator-activated receptor-\u03b1 mediates the anti-inflammatory actions of palmitoylethanolamide","volume":"67","author":"Lo Verme","year":"2005","journal-title":"Mol Pharmacol."},{"issue":"10","key":"10.1093\/jn\/nxac154_bib19","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nri912","article-title":"Emerging roles of PPARs in inflammation and immunity","volume":"2","author":"Daynes","year":"2002","journal-title":"Nat Rev Immunol."},{"issue":"1","key":"10.1093\/jn\/nxac154_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1124\/mol.104.006353","article-title":"The nuclear receptor peroxisome proliferator-activated receptor-\u03b1 mediates the anti-inflammatory actions of palmitoylethanolamide","volume":"67","author":"Lo Verme","year":"2005","journal-title":"Mol Pharmacol."},{"issue":"21","key":"10.1093\/jn\/nxac154_bib21","doi-asserted-by":"crossref","first-page":"7942","DOI":"10.3390\/ijms21217942","article-title":"The basal pharmacology of palmitoylethanolamide","volume":"21","author":"Rankin","year":"2020","journal-title":"Int J Mol Sci."},{"key":"10.1093\/jn\/nxac154_bib22","doi-asserted-by":"crossref","first-page":"109856","DOI":"10.1016\/j.mehy.2020.109856","article-title":"Sodium chromo-glycate and palmitoylethanolamide: a possible strategy to treat mast cell-induced lung inflammation in COVID-19","volume":"143","author":"Gigante","year":"2020","journal-title":"Med Hypotheses."},{"issue":"4","key":"10.1093\/jn\/nxac154_bib23","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3390\/ph14040336","article-title":"Ultramicronized palmitoylethanolamide (um-PEA): a new possible adjuvant treatment in COVID-19 patients","volume":"14","author":"Noce","year":"2021","journal-title":"Pharmaceuticals."},{"issue":"2","key":"10.1093\/jn\/nxac154_bib24","first-page":"3","article-title":"Increased absorption of palmitoylethanolamide using a novel dispersion technology system (LipiSperse) study design and procedures","volume":"5","author":"Briskey","year":"2020","journal-title":"J nutraceuticals Food Sci."},{"issue":"7","key":"10.1093\/jn\/nxac154_bib25","doi-asserted-by":"crossref","first-page":"907.e7","DOI":"10.1016\/j.cmi.2018.10.016","article-title":"Effective chemical virus inactivation of patient serum compatible with accurate serodiagnosis of infections","volume":"25","author":"Remy","year":"2019","journal-title":"Clin Microbiol Infect."},{"key":"10.1093\/jn\/nxac154_bib26","doi-asserted-by":"crossref","first-page":"104290","DOI":"10.1016\/j.phrs.2019.104290","article-title":"Can coenzyme Q10 supplementation effectively reduce human tumor necrosis factor-\u03b1 and interleukin-6 levels in chronic inflammatory diseases? A systematic review and meta-analysis of randomized controlled trials","volume":"148","author":"Farsi","year":"2019","journal-title":"Pharmacol Res."},{"issue":"1","key":"10.1093\/jn\/nxac154_bib27","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Series B Stat Methodol."},{"issue":"8","key":"10.1093\/jn\/nxac154_bib28","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/ni1491","article-title":"P-selectin primes leukocyte integrin activation during inflammation","volume":"8","author":"Wang","year":"2007","journal-title":"Nat Immunol."},{"issue":"3","key":"10.1093\/jn\/nxac154_bib29","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/0092-8674(93)80055-J","article-title":"Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice","volume":"74","author":"Mayadas","year":"1993","journal-title":"Cell."},{"issue":"1","key":"10.1093\/jn\/nxac154_bib30","doi-asserted-by":"crossref","first-page":"13397","DOI":"10.1038\/s41598-019-49635-7","article-title":"Platelet P-selectin triggers rapid surface exposure of tissue factor in monocytes","volume":"9","author":"Ivanov","year":"2019","journal-title":"Sci Rep."},{"issue":"8","key":"10.1093\/jn\/nxac154_bib31","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/sj.jhh.1001447","article-title":"Effects of efonidipine on platelet and monocyte activation markers in hypertensive patients with and without type 2 diabetes mellitus","volume":"16","author":"Nomura","year":"2002","journal-title":"J Hum Hypertens."},{"issue":"8","key":"10.1093\/jn\/nxac154_bib32","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1532-5415.1999.tb01288.x","article-title":"Platelet hyperactivity in hypertensive older patients is controlled by lowering blood pressure","volume":"47","author":"Riondino","year":"1999","journal-title":"J Am Geriatr Soc."},{"issue":"6","key":"10.1093\/jn\/nxac154_bib33","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study","volume":"46","author":"Helms","year":"2020","journal-title":"Intensive Care Med."},{"issue":"1","key":"10.1093\/jn\/nxac154_bib34","doi-asserted-by":"crossref","first-page":"16290","DOI":"10.1038\/s41598-021-95397-6","article-title":"Altered platelet and coagulation function in moderate-to-severe COVID-19","volume":"11","author":"Litvinov","year":"2021","journal-title":"Sci Rep."},{"issue":"5","key":"10.1093\/jn\/nxac154_bib35","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1161\/ATVBAHA.121.316101","article-title":"Endothelial injury in COVID-19 and acute infections: putting the pieces of the puzzle together","volume":"41","author":"Levy","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"11","key":"10.1093\/jn\/nxac154_bib36","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1182\/blood.2020007214","article-title":"Platelet gene expression and function in patients with COVID-19","volume":"136","author":"Manne","year":"2020","journal-title":"Blood."},{"issue":"7","key":"10.1093\/jn\/nxac154_bib37","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/09537104.2018.1430358","article-title":"Measuring and interpreting platelet-leukocyte aggregates","volume":"29","author":"Finsterbusch","year":"2018","journal-title":"Platelets."},{"key":"10.1093\/jn\/nxac154_bib38","doi-asserted-by":"crossref","first-page":"119634","DOI":"10.1016\/j.lfs.2021.119634","article-title":"Soluble P-selectin as a potential diagnostic and prognostic biomarker for COVID-19 disease: a case-control study","volume":"277","author":"Karsli","year":"2021","journal-title":"Life Sci."},{"issue":"4","key":"10.1093\/jn\/nxac154_bib39","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molmed.2004.02.008","article-title":"Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation","volume":"10","author":"Furie","year":"2004","journal-title":"Trends Mol Med."},{"issue":"6","key":"10.1093\/jn\/nxac154_bib40","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/infdis\/jiaa756","article-title":"Association of neutrophil activation, more than platelet activation, with thrombotic complications in coronavirus disease 2019","volume":"223","author":"Petito","year":"2021","journal-title":"J Infect Dis."},{"key":"10.1093\/jn\/nxac154_bib41","doi-asserted-by":"crossref","first-page":"102424","DOI":"10.1016\/j.bcmd.2020.102424","article-title":"Leukocyte adhesion to P-selectin and the inhibitory role of crizanlizumab in sickle cell disease: a standardized microfluidic assessment","volume":"83","author":"Man","year":"2020","journal-title":"Blood Cells Mol Dis."},{"key":"10.1093\/jn\/nxac154_bib42","first-page":"1","article-title":"The inhibition of P-Selectin reduced severe acute lung injury in immunocompromised mice","volume":"2020","author":"Liu","year":"2020","journal-title":"Oxid Med Cell Long."},{"issue":"1","key":"10.1093\/jn\/nxac154_bib43","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1146\/annurev-med-042220-012417","article-title":"COVID-19: inflammatory profile","volume":"73","author":"Wang","year":"2022","journal-title":"Annu Rev Med."},{"issue":"1","key":"10.1093\/jn\/nxac154_bib44","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s10787-020-00773-9","article-title":"The role and therapeutic potential of NF-kappa-B pathway in severe COVID-19 patients","volume":"29","author":"Hariharan","year":"2021","journal-title":"Inflammopharmacology."},{"issue":"2","key":"10.1093\/jn\/nxac154_bib45","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/SHK.0000000000000578","article-title":"Protective effects of ultramicronized palmitoylethanolamide (PEA-um) in myocardial ischaemia and reperfusion injury in vivo","volume":"46","author":"Di Paola","year":"2016","journal-title":"Shock."},{"issue":"4","key":"10.1093\/jn\/nxac154_bib46","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/SHK.0b013e318267bbb9","article-title":"Palmitoylethanolamide reduces early renal dysfunction and injury caused by experimental ischemia and reperfusion in mice","volume":"38","author":"Di Paola","year":"2012","journal-title":"Shock."},{"issue":"9","key":"10.1093\/jn\/nxac154_bib47","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3390\/metabo11090592","article-title":"Ultramicronized palmitoylethanolamide inhibits NLRP3 inflammasome expression and pro-inflammatory response activated by SARS-CoV-2 spike protein in cultured murine alveolar macrophages","volume":"11","author":"Del Re","year":"2021","journal-title":"Metabolites."},{"issue":"11","key":"10.1093\/jn\/nxac154_bib48","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.3390\/ijms22115533","article-title":"Management of acute lung injury: palmitoylethanolamide as a new approach","volume":"22","author":"Peritore","year":"2021","journal-title":"Int J Mol Sci."},{"issue":"3","key":"10.1093\/jn\/nxac154_bib49","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/FJC.0b013e3181d2644d","article-title":"Activation of cannabinoid CB2 receptor ameliorates atherosclerosis associated with suppression of adhesion molecules","volume":"55","author":"Zhao","year":"2010","journal-title":"J Cardiovasc Pharmacol."},{"issue":"1","key":"10.1093\/jn\/nxac154_bib50","doi-asserted-by":"crossref","first-page":"7363","DOI":"10.1038\/s41598-017-07519-8","article-title":"A novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum","volume":"7","author":"Musella","year":"2017","journal-title":"Sci Rep."},{"issue":"1","key":"10.1093\/jn\/nxac154_bib51","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1124\/mol.105.019117","article-title":"Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor \u03b3 independently of cannabinoid receptors 1 and 2","volume":"70","author":"Rockwell","year":"2006","journal-title":"Mol Pharmacol."},{"issue":"7","key":"10.1093\/jn\/nxac154_bib52","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/bph.13084","article-title":"The anti-inflammatory mediator palmitoylethanolamide enhances the levels of 2-arachidonoyl-glycerol and potentiates its actions at TRPV1 cation channels","volume":"173","author":"Petrosino","year":"2016","journal-title":"Br J Pharmacol."},{"issue":"1","key":"10.1093\/jn\/nxac154_bib53","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12933-021-01359-7","article-title":"Persistent clotting protein pathology in long COVID\/post-acute sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin","volume":"20","author":"Pretorius","year":"2021","journal-title":"Cardiovasc Diabetol."}],"container-title":["The Journal of Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002231662308598X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002231662308598X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jn\/article-pdf\/152\/10\/2218\/46347889\/nxac154.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jn\/article-pdf\/152\/10\/2218\/46347889\/nxac154.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T05:12:24Z","timestamp":1727932344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002231662308598X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":53,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S002231662308598X"],"URL":"https:\/\/doi.org\/10.1093\/jn\/nxac154","relation":{},"ISSN":["0022-3166"],"issn-type":[{"type":"print","value":"0022-3166"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Palmitoylethanolamide Reduces Proinflammatory Markers in Unvaccinated Adults Recently Diagnosed with COVID-19: A Randomized Controlled Trial","name":"articletitle","label":"Article Title"},{"value":"The Journal of Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1093\/jn\/nxac154","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 American Society for Nutrition. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}